Home » Stocks » CMII

CM Life Sciences II, Inc. (CMII)

Stock Price: $11.35 USD -0.65 (-5.42%)
Updated May 10, 2021 11:18 AM EDT - Market open
Market Cap 329.15M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 29.00M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $11.35
Previous Close $12.00
Change ($) -0.65
Change (%) -5.42%
Day's Open 12.49
Day's Range 11.35 - 11.35
Day's Volume 480
52-Week Range 11.31 - 14.27

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (Nasdaq: CMIIU) (the “Company”) today announced that holders of the Company's units sold in its initial public offering may elect to separately trade ...

Other stocks mentioned: CMIIU
3 weeks ago - Business Wire

SomaLogic is joining the growing number of companies going public via special purpose acquisition companies. The Boulder, Colorado-based health care company plans to merge with CM Life Sciences II Inc. ...

Other stocks mentioned: CMIIU
1 month ago - GuruFocus

A leader in the proteomics field is going public with a SPAC deal announced Monday. The SPAC Deal: SomaLogic announced a SPAC deal with CM Life Sciences II Inc (NASDAQ: CMIIU), valuing the company at $1...

Other stocks mentioned: CMIIU
1 month ago - Benzinga

NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial...

Other stocks mentioned: CMIIU
1 month ago - Business Wire

NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (the “Company”) announced today that it closed its initial public offering of 27,600,000 units at $10.00 per unit, including 3,600,000 units issued pu...

2 months ago - Business Wire

CM Life Sciences II Inc. (the “Company”) announced today that it priced its initial public offering of 24,000,000 units at $10.00 per unit.

2 months ago - Business Wire

CM Life Sciences II, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC

About CMII

CM Life Sciences II is a newly organized blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on our management team’s background and experience to identify promising opportunities in the life sciences sector. Our sponsor is an affiliate of Eli Casdin, founder and Chief Investment Officer of Casdin Capital, and of Keith Meister, founder and Chief Investment Officer of... [Read more...]

Industry
Shell Companies
IPO Date
Feb 23, 2021
CEO
Eli Casdin
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
CMII
Full Company Profile